Recent sequencing data from human Alzheimer’s disease patients and healthy controls demonstrated that healthy controls have three subpopulations of OPCs, and that one of these populations expressed high levels of Clusterin, one of the genes we identified as significantly upregulated in OPC158. This evidence concerns the gene CLU and Alzheimer disease.